Microbiota transplants: the concept of ‘microbiome mismatching’ explored
Research highlight related to: DeLeon O., Mocanu M., Tan A., Sidebottom A.M., Koval J. et al. Cell (2025);188,…
Unexpected traces of bacteria found within brain tumors
Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain…
Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expansion plan
Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet…
PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer
PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR…
Machine learning approaches overcome imbalanced clinical data for intraoral free flap monitoring
Artificial intelligence has revolutionized medical imaging, particularly in diagnosis and segmentation. Numerous studies have employed artificial neural networks…
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis
Bhutani M, Foureau DM, Atrash S, Voorhees PM, Usmani SZ. Extramedullary multiple myeloma. Leukemia. 2020;34:1–20. Article PubMed Google…
Personalized circulating tumor DNA dynamics inform survival and response to immune checkpoint blockade in recurrent/metastatic head and neck cancer
Patient baseline characteristics One hundred thirty-seven blood samples were collected between January 2021 and December 2022, with a…
Development and validation of a nomogram-based predictive model for recurrence risk of uterine leiomyoma after myomectomy
Baseline characteristics The clinical cases included were randomly divided into a training cohort and a validation cohort at…
Early clinical trial supports MASL as a targeted oral cancer treatment
Rowan University and Sentrimed®, a clinical-stage biopharmaceutical company focused on developing safer, orally dosed oncology therapies, today announced…